Is a complete BVMF/ABBV34 research report available?

No complete published report is available for bvmf/ABBV34 (BVMF/ABBV34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bvmf/ABBV34 stock profile: metrics, valuation and analysis

Market cap	2.3T
Revenue (ttm)	333.6B
Net income (ttm)	32.5B
EPS (ttm)	R$18.3
P/E (trailing)	69.7x
P/E (forward)	16.6x
Dividend	R$1.45 (1.83%)
Volume	13,688
Beta	0.28

All BVMF/ABBV34 indicators

Market & fundamental data

Available fields

234

Groups with data

Currency

USD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	57,000
Employees Change	2,000%
Employees Change Percent	3.64
Enterprise value	BRL 2.6T
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-09-11
Market cap	BRL 2.3T
Price	BRL 80.13
Price currency	BRL
Rev Per Employee	5,852,122.61x
Sector	Healthcare
Sector PE	44.4
Sector PE Fwd	12.1
Sic	2836
Symbol	bvmf/ABBV34
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.43%
EV Earnings	79.83x
EV/EBIT	22.18x
EV/EBITDA	16.3x
EV/FCF	27.49x
EV/Sales	7.89x
FCF yield	4.17%
Forward P/E	16.56x
P/B ratio	-74.23x
P/E ratio	69.71x
P/S ratio	6.79x
PE Ratio10 Y	41.3x
PE Ratio3 Y	81.44x
PE Ratio5 Y	58.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	35.56%
EBITDA Margin	47.78%
FCF margin	28.69%
Gross margin	72.79%
Gross Profit	BRL 242.8B
Gross Profit Growth	12.78%
Gross Profit Growth Q	14.64%
Gross Profit Growth3 Y	5.88%
Gross Profit Growth5 Y	5.07%
Net Income	BRL 32.5B
Net Income Growth	67.69%
Net Income Growth Q	285.18%
Net Income Growth Qo Q	424.16%
Net Income Growth3 Y	-10.12%
Net Income Growth5 Y	-1.02%
Pretax Margin	13.51%
Profit Margin	9.8%
Profit Per Employee	BRL 569,888
ROA	10.51
Roa5y	8.68
ROCE	24.49
Roe5y	1,295.2
ROIC	17.7
Roic5y	21.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	23.87%
Cagr1y	15.44%
Cagr3y	22.87%
Cagr5y	21.04%
Div CAGR10	22.99%
Div CAGR3	4.72%
Div CAGR5	6.23%
EPS Growth	68.54
EPS Growth Q	290.4
EPS Growth Qo Q	422.7
EPS Growth3 Y	-10.05
EPS Growth5 Y	-0.92
FCF Growth	-0.16%
FCF Growth Q	-36.24%
FCF Growth Qo Q	-12.63%
FCF Growth3 Y	-9.78%
FCF Growth5 Y	-1.43%
OCF Growth	1.16%
OCF Growth Q	-33.32%
OCF Growth Qo Q	-10.26%
OCF Growth10 Y	9.1%
OCF Growth3 Y	-8.59%
OCF Growth5 Y	-0.94%
Revenue Growth	10.39x
Revenue Growth Q	10.16x
Revenue Growth Qo Q	13.25x
Revenue Growth3 Y	4.75x
Revenue Growth5 Y	3.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.47
Assets	BRL 700B
Cash	BRL 34B
Current Assets	BRL 172B
Current Liabilities	BRL 212.7B
Debt	BRL 367.2B
Debt EBITDA	BRL 2.28
Debt FCF	BRL 3.89
Equity	BRL -30.5B
Interest Coverage	7.85
Liabilities	BRL 730.5B
Long Term Assets	BRL 528B
Long Term Liabilities	BRL 517.8B
Net Cash	BRL -333.2B
Net Cash By Market Cap	BRL -14.72
Net Debt EBITDA	BRL 2.09
Net Debt FCF	BRL 3.53
Tangible Book Value	BRL -469.3B
Tangible Book Value Per Share	BRL -266
WACC	5.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.81
Inventory Turnover	3.47
Net Working Capital	BRL -32.1B
Quick ratio	0.49
Working Capital	BRL -41.3B
Working Capital Turnover	BRL -36.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%
Dividend Growth	7.6%
Dividend Growth Years	6%
Dividend per share	BRL 1.45
Dividend Years	11
Dividend Yield	1.83%
Ex Div Date	2026-07-14
Last Dividend	BRL 0.07
Payout Frequency	Quarterly
Payout Ratio	189.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	750.36%
1Y total return	15.43%
200-day SMA	74.17
3Y total return	85.51%
50-day SMA	81.63
50-day SMA vs 200-day SMA	50over200
5Y total return	159.74%
All Time High	86.95
All Time High Change	-7.45%
All Time High Date	2026-08-20
All Time Low	11.7
All Time Low Change	587.9%
All Time Low Date	2017-02-14
ATR	1.62
Beta	0.28
Ch YTD	2.02
High	80.13
High52	86.95
High52 Date	2026-08-20
High52ch	-7.84%
Low	79.21
Low52	58.81
Low52 Date	2026-04-29
Low52ch	36.25%
Ma50ch	-1.42%
Price vs 200-day SMA	8.5%
RSI	44.02
RSI Monthly	60.38
RSI Weekly	55.05
Sharpe ratio	0.45x
Sharpe Ratio3y	0.73x
Sharpe Ratio5y	0.59x
Sortino ratio	0.82
Sortino Ratio3y	1.24
Sortino Ratio5y	1.03
Total Return	1.81%
Tr YTD	3.62
Tr1m	3.27%
Tr1w	-3.43%
Tr3m	10.75%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,763,987,514%
Net Borrowing	2,135,018,182
Shares Insiders	0.07%
Shares Institutions	76.64%
Shares Qo Q	-0.23%
Shares Yo Y	0.03%
Short Ratio	2.87

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 89.3B
Adjusted OCF	96,005,404,800
Average Volume	1,192.6x
Bv Per Share	-17.4
CAPEX	BRL -6.7B
Ch10y	525.8
Ch1m	3.27
Ch1w	-3.43
Ch1y	13.1
Ch3m	10.22
Ch3y	73.13
Ch5y	129.9
Ch6m	8.96
Change	1.16%
Change From Open	1.16
Close	79.21
Days Gap	0
Depreciation Amortization	40,192,483,431
Dollar Volume	1,096,819.4
Earnings Date	2026-10-29
EBIT	BRL 118.6B
EBITDA	BRL 159.4B
EPS	BRL 18.34
F Score	8
FCF	BRL 94.3B
FCF EV Yield	3.64x
Financing CF	-66,785,692,800
Fiscal Year End	December
Founded	2,012
Goodwill	181,420,360,781
Income Tax	BRL 12.3B
Investing CF	-33,664,838,400
Is Primary Listing	0
Last Earnings Date	2026-07-31
Last Report Date	2026-06-30
Last Split Date	2022-11-21
Last Split Type	Forward
Lynch Fair Value	BRL 5.68
Lynch Upside	-92.83
Ma150	73.72
Ma150ch	9.16%
Ma20	83.08
Ma20ch	-3.14%
Net CF	528,441,600
Next Earnings Date	2026-10-29
Open	79.21
P FCF Ratio	24
P FCF Ratio SBC	25.36
P OCF Ratio	22.41
P OCF Ratio SBC	23.59
Payment Date	2026-08-20
Position In Range	100
Ppne	29,604,223,404
Price Date	2026-09-09
Price EBITDA	BRL 14.21
Relative Volume	11.48x
Revenue	333,570,988,800x
SBC By Revenue	1.52x
Share Based Comp	5,056,460,800
Tax By Revenue	3.7x
Tax Rate	27.39%
Tr6m	10.11%
Volume	13,688
Z Score	2.42

BVMF/ABBV34 (BVMF/ABBV34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/ABBV34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/ABBV34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BVMF/ABBV34

Frequently asked questions